{"schema_version":"secwatch.filing_event.v1","accession":"0001822479-25-000041","form_type":"8-K","ticker":"SHC","cik":"0001822479","company_name":"Sotera Health Co","filed_at":"2025-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.144024+00:00","generated_at":"2026-05-17T16:46:02.555781+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sotera Health Q2 revenue up 6.4% to $294M; Adj EBITDA +9.8% to $151M; raises FY outlook","bullets":["Q2 net revenues $294M (+6.4% YoY); constant currency +6.0%; net income $8M ($0.03 diluted EPS).","Adjusted EBITDA $151M (+9.8% YoY); Adjusted EPS $0.20 vs $0.19 prior year.","Company raises full-year 2025 outlook: net revenue growth 4.5%-6.0%, Adj EBITDA growth 6.0%-7.5% constant currency.","Net income impacted by $34M pending settlement related to ethylene oxide claims against Sterigenics.","First-half 2025 net revenues $549M (+4.6% YoY); net loss $5M due to settlements totaling $65M."],"urls":{"canonical":"https://secwatch.observer/filing/0001822479-25-000041","json":"https://secwatch.observer/filing/0001822479-25-000041.json","markdown":"https://secwatch.observer/filing/0001822479-25-000041.md","text":"https://secwatch.observer/filing/0001822479-25-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/0001822479-25-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822479/000182247925000041/shc-20250808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T16:46:02.555781+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}